S.H.R.O. Institution

Administration
Achievements
About Us
History
Mission
Patents

Patents Awarded

The following patents have been awarded to S.H.R.O. and the Sbarro Institute for Cancer Research and Molecular Medicine under the direction of Antonio Giordano, M.D., Ph.D.:

U.S. Patent, "Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor," issued October 10, 1995, Antonio Giordano.

U.S. Patent, "Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor," issued July 2, 1996, Antonio Giordano.

U.S. Patent, "Human Cyclin-Dependent Kinase- like Proteins and Methods of Using the Same," issued on October 7, 1997, Antonio Giordano.

U.S. Patent, "Human Retinoblastoma-Related (pRb2/p130) Genomic DNA and Methods of Detecting Mutations Therein," issued on Sep. 15, 1998, Antonio Giordano and A. Baldi.

U.S. Patent, "Human Cyclin-Dependent Kinase- like Proteins and Methods of Using the Same," issued on December 19, 2000, Antonio Giordano.

U.S. Patent, "Method for the Diagnosis and Prognosis of Cancer," issued on November 24, 1998, Antonio Giordano.

U.S. Patent, "Determination of Cyclin-Dependent Kinase Inhibitor p27 levels as a prognostic factor in cancer patients." issued on January 30, 2001, Antonio Giordano.

U.S. Patent, "pRb2/p130 Peptide Inhibitors of cdk2 Kinase activity," issued on October 2, 2001, Antonio Giordano.

Pending:
Four (4) additional patents have been filed and currently under examination.

Institution	Donations	Research	Fellowships	News & Events
Credits	Advanced	Site Map	Home Page	Contact Info	Links